Turning Point Brands, Inc. (TPB) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This summary covers the unaudited quarterly report on Form 10-Q for Turning Point Brands, Inc. for the period ended June 30, 2026. TPB is a leading manufacturer and distributor of branded consumer products, operating primarily through two segments: Zig-Zag products (rolling papers, cigars, accessories) and Stoker's products (moist snuff, loose-leaf tobacco, modern oral products). The company reported a significant increase in consolidated net sales driven by the Stoker's segment, partially offset by declines in the Zig-Zag segment.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | Q2 2025 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Net Sales | $142.96 million | $116.63 million | $267.24 million | $223.07 million |
| Gross Profit | $93.70 million (65.5% margin) | $66.62 million (57.1% margin) | $162.00 million (60.6% margin) | $126.23 million (56.6% margin) |
| Operating Income | $16.71 million | $26.33 million | $29.20 million | $49.52 million |
| Net Income (Consolidated) | $10.30 million | $16.96 million | $24.24 million | $32.75 million |
| Net Income Attributable to TPB | $3.60 million | $14.48 million | $15.27 million | $28.88 million |
| Diluted EPS (Attributable to TPB) | $0.18 | $0.79 | $0.77 | $1.58 |
| Cash and Cash Equivalents | $268.31 million | $222.76 million (Dec 31, 2025) | $268.31 million | $222.76 million (Dec 31, 2025) |
| Long-Term Debt | $294.15 million | $293.63 million (Dec 31, 2025) | $294.15 million | $293.63 million (Dec 31, 2025) |
| Operating Cash Flow (YTD) | $4.07 million | $29.23 million | $4.07 million | $29.23 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 22.6% in Q2 and 19.8% YTD compared to 2025. This was driven by a 54.5% increase in the Stoker's segment (primarily modern oral products), which more than offset a 24.8% decline in the Zig-Zag segment (due to declines in U.S. papers, wraps, and the Clipper lighter business).
- Margin Expansion: Gross profit margins improved significantly (65.5% in Q2 vs. 57.1% prior year) due to favorable product mix and a $12.3 million reduction in cost of sales resulting from IEEPA tariff refunds received in June 2026.
- Operating Income Decline: Despite higher gross profit, operating income decreased 36.5% in Q2 and 41.0% YTD. This was primarily due to a 91.1% increase in Selling, General, and Administrative (SG&A) expenses, driven by increased shipping costs, sales headcount, and marketing spend to support modern oral product growth.
- Net Income Attributable to TPB: Net income attributable to the company dropped 75.2% in Q2 and 47.1% YTD. This decline is largely attributed to a significant increase in net income attributable to non-controlling interests (joint ventures), which rose from $2.48 million to $6.70 million in Q2.
- Capital Structure: The company raised approximately $59.6 million in net proceeds through an At-The-Market (ATM) equity offering in Q2. There were no share repurchases during the period.
Guidance, Outlook, and Risks
- Tariff Refunds: The company received $17.8 million in refunds for previously paid IEEPA tariffs. $12.3 million was recognized as a reduction to cost of goods sold, while $5.5 million was capitalized. Management continues to monitor potential future tariff changes under Section 122 of the Trade Act of 1974.
- Regulatory Environment: Significant costs are associated with FDA Premarket Tobacco Product Applications (PMTA). Management adjusts for these costs in non-GAAP metrics, viewing them as non-traditional regulatory expenses. The company faces ongoing risks related to flavor bans and FDA enforcement priorities.
- Liquidity: As of June 30, 2026, the company held $268.3 million in cash and had $70.7 million in available borrowing capacity under its 2023 ABL Facility. No borrowings were outstanding on the ABL facility.
- Debt Covenants: The company is in compliance with all covenants under its 7.625% Senior Secured Notes due 2032. Dividends are permitted as restricted payments provided earnings and market capitalization requirements are met.
- Forward-Looking Risks: Key risks include declining tobacco sales, supply chain disruptions, competition from illicit sources, product liability litigation, and the impact of inflation on consumer purchasing power.
Investor Verification Checklist
- Non-Controlling Interest Impact: Verify the sustainability of the high net income attributable to non-controlling interests ($6.7M in Q2) and its dilutive effect on TPB's reported net income.
- SG&A Expense Trajectory: Assess whether the 91% increase in SG&A expenses is a one-time step-up for growth or a permanent increase in the cost structure.
- Zig-Zag Segment Decline: Confirm the long-term outlook for the Zig-Zag segment, which saw a 24.8% revenue drop, specifically regarding the Clipper lighter business and U.S. papers.
- Tariff Refund Recurrence: Note that the $12.3 million tariff refund is a non-recurring item that significantly boosted gross margins; exclude this when analyzing organic margin trends.
- Equity Offering Dilution: Review the impact of the recent $59.6 million ATM offering on share count and future earnings per share.